Related Experiment Video

Updated: Apr 23, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

778

Importance of risk factor management in diabetic patients and reduction in Stage B heart failure

G Murtagh1, J O Connell2, E O Connell1

  • 1From the The Chronic Cardiovascular Disease Management Unit, St Vincent's University Hospital Health Care Group, Elm Park, Dublin 4, Ireland, Department of Endocrinology, St Vincent's University Hospital Health Care Group, Elm Park, Dublin 4, Ireland and School of Medicine and Medical Sciences, University College Dublin, Belfield, Dublin 4, Ireland.

QJM : Monthly Journal of the Association of Physicians
|September 21, 2014
PubMed

Insights

Diabetes increases heart failure risk, but good risk factor control in diabetic patients may prevent diabetic cardiomyopathy. Effective management is key for cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Diabetology
  • Heart Failure Research

Background:

  • Diabetic cardiomyopathy is a known complication, increasing heart failure risk in diabetic patients.
  • Contemporary risk factor control may influence the prevalence of diabetes-associated cardiomyopathy.

Purpose of the Study:

  • To assess the current impact of diabetes mellitus on cardiomyopathy prevalence.
  • To evaluate this impact with and without adjusting for risk factor control in at-risk patients.

Main Methods:

  • Cross-sectional study of patients at risk for heart failure (St Vincent's Screening to Prevent Heart Failure cohort).
  • Comparison of diabetic patients with those having other cardiovascular risk factors, with multiple matching criteria (age, gender, BMI, blood pressure, LDL cholesterol).

Main Results:

  • No significant difference in Stage B heart failure (asymptomatic cardiomyopathy) between diabetic and non-diabetic patients when matched for age and gender.
  • Stage B heart failure was more prevalent in diabetic patients (22.2%) compared to non-diabetic patients (16.4%) after controlling for risk factors (P=0.048).

Conclusions:

  • Effective risk factor management in diabetic patients appears to mitigate the direct negative impact of diabetes on left ventricular structure and function.
  • Highlights the critical importance of robust risk factor control for improving cardiovascular outcomes in diabetic individuals at risk for heart failure.
Abstract

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

746

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
611
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
748
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.6K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.4K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
777